Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Biotechnol Bioeng ; 108(9): 2237-40, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21495013

ABSTRACT

Microbial cellulose (MC) is being investigated for various applications in the field of biomedical engineering. Gluconacetobacter xylinus is able to produce pure cellulose in the form of a hydrogel ("pellicle"). The pellicle consists of a defined tridimensional structure that is sensitive to mechanical stress during the process of formation. The bacteria, however, are obligate aerobic and need to be supplied with oxygen. These two objectives are often conflicting. A lab-scale membrane bioreactor prototype was developed which is able to efficiently produce a MC pellicle with a homogeneous layered structure. A hydrophilic microfiltration polyethersulfone membrane separates the bacteria from the cultivation medium. This setup allows the free convective exchange of the cultivation medium, while providing mechanical support for the continuous formation of the MC layer. Thickness of the MC layer was measured online by a laser triangulation sensor. One hundred and twenty five gram cellulose dry weight/m(2) membrane surface were produced within a process time of 330 h. Membrane bioreactors may be used to produce homogenous MC layers in a variety of shapes suitable for biomedical applications.


Subject(s)
Bioreactors/microbiology , Cellulose/metabolism , Gluconacetobacter xylinus/metabolism , Membranes, Artificial , Cellulose/ultrastructure , Microscopy, Electron, Scanning
2.
Exp Cell Res ; 183(2): 434-42, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2767158

ABSTRACT

The amount of TRITC-labeled bovine serum albumin (TRITC-BSA) released from the tip of standardized microcapillaries at different injection pressures and times was investigated. Three test systems were used: (a) formation of droplets of the test solution (TRITC-BSA) in paraffin oil, (b) injection of the test solution into buffer droplets suspended in paraffin oil, and (c) injection into living 3T3 cells. The amount of test substance released was determined by scanning fluorometry. The first procedure (a) allows the fluorometrically determined amount of TRITC-BSA to be related to the volume of released test solution. For this rather large pressures (about 700 hPa) are required to overcome the surface forces counteracting droplet formation. The volume of the spheres was evaluated from photomicrographs of the droplets. The values obtained correlate very well with those determined by measuring the fluorescence emitted by the droplets. Injection into preformed droplets of buffer (b) can be performed with pressures in the range used for injecting cells (50-400 hPa). High reproducibility in the volume released is obtained with a single microcapillary; however, large variations exist between different capillaries, although these should theoretically be of equal diameter. The volume injected into living cells (c) under a given condition may vary by a factor of 5 or more. This variation may be due to viscosity differences of cytoplasm. We recommend, therefore, injection of fluorescent marker substances together with the test substance, enabling the injected volume to be determined by scanning fluorometry or by image analysis.


Subject(s)
Microinjections/methods , Rhodamines , Serum Albumin, Bovine , Xanthenes , Animals , Cells, Cultured , Fibroblasts/cytology , Fluorescent Dyes , Mice , Microscopy, Fluorescence , Pressure , Spectrometry, Fluorescence
3.
Cell Differ ; 16(3): 187-202, 1985 May.
Article in English | MEDLINE | ID: mdl-2408765

ABSTRACT

A series of monoclonal antibodies against a developmentally regulated protein of Dictyostelium discoideum, the contact site A glycoprotein, were used in immunoblots to label proteins of cells harvested at three stages of development: during the growth phase, at the aggregation competent stage, and at the slug stage. The antibodies fell into two groups according to their reactivity with partially or fully deglycosylated forms of the 80 kDa glycoprotein. Group A antibodies reacted not only with a 66 kDa, but also with a 53 kDa product of tunicamycin-treated wild-type cells, and they reacted with a 68 kDa component produced by HL220, a mutant that carries a specific defect in glycosylation. The 68 kDa product of the mutant was not completely unglycosylated. Like the 80 kDa glycoprotein of the wild type, which carried sulfate at carbohydrate residues, the mutant product was sulfated. In the presence of tunicamycin, the mutant produced a 53 kDa component indistinguishable from that of the wild type, which represents, most likely, the non-N-glycosylated protein portion of the contact site A glycoprotein. The group A antibodies showed almost no cross-reactivity with other proteins of the developmental stages tested, in accord with their postulated specificity for the protein moiety of the contact site A molecule. Group B antibodies did not react with the 53 kDa product of tunicamycin-treated cells, nor with the 68 kDa component of mutant HL220. These antibodies were of varying specificity. Some of them were almost as specific as group A antibodies, others cross-reacted with many proteins, particularly of the slug stage. Competition or non-competition between various group B antibodies for binding to the contact site A glycoprotein allowed sub-classification of these antibodies. According to two criteria, group B antibodies were characterized as anti-carbohydrate antibodies: (1) some of these antibodies were blocked by N-acetylglucosamine; (2) none of them reacted with the 68 kDa product or any other protein of mutant HL220. These results indicate that the 80 kDa glycoprotein carries two types of carbohydrate: type 1 carbohydrate that is sulfated and present on the 68 kDa product of mutant HL220, and type 2 carbohydrate that reacts with group B antibodies and is present on the 66 kDa product of tunicamycin-treated wild-type cells. Type 2 carbohydrate moieties are also present on many glycoproteins that are enriched in the prespore area of the slugs.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Carbohydrates/analysis , Dictyostelium/cytology , Glycoproteins/analysis , Antibodies, Monoclonal , Cell Division , Electrophoresis, Polyacrylamide Gel , Epitopes/analysis , Molecular Weight , Sulfates/metabolism , Sulfur Radioisotopes
4.
J Cell Sci ; 73: 49-68, 1985 Feb.
Article in English | MEDLINE | ID: mdl-4019595

ABSTRACT

HL220, a modB mutant that lacks a modification of certain membrane proteins of Dictyostelium discoideum, has been shown to aggregate and to form EDTA-stable intercellular contacts typical of aggregating wild-type cells. A developmentally regulated glycoprotein of 80 X 10(3) apparent molecular weight has been identified as a target site of adhesion-blocking Fab and thought to be involved in EDTA-stable cell contact formation (Müller & Gerisch, 1978). In the HL220 mutant this glycoprotein is no longer recognized by a modB-specific antibody. Therefore, it has been suggested that the 80 X 10(3) Mr glycoprotein, or a modification on it, is not required for the EDTA-stable cell contact of aggregating cells. We show that HL220 synthesizes an equivalent of the 80 X 10(3) Mr glycoprotein with an apparent molecular weight of 68 X 10(3). The mutant product reacted with certain monoclonal antibodies highly specific for the 80 X 10(3) Mr glycoprotein in the wild type, and was developmentally regulated like the 80 X 10(3) Mr glycoprotein. These results indicate that the 68 X 10(3) Mr protein of the mutant lacks a modification, most likely an oligosaccharide residue, the absence of which causes the substantial shift of the apparent molecular weight from 80 X 10(3) to 68 X 10(3). Monoclonal antibodies that did not react with proteins of the mutant could be classified according to their reactions with different sub-sets of wild-type proteins. These results indicate that the proteins that reacted with either one or the other antibody were not modified by a uniform structure. The modification rather varies from one sub-set of cross-reacting proteins to another, suggesting differences between the glycosyl residues of the partially cross-reacting proteins. HL220 cells showed strongly reduced EDTA-stable contact formation under our conditions. EDTA-sensitive intercellular adhesion was undetectable in the mutant, whereas adhesion of the cells to the substratum appeared to be strengthened. The rear ends of the cells, in particular, were tightly attached to glass or Teflon surfaces. The mutant cells were capable of responding chemotactically. Propagated excitation waves like those known to be based on periodic cyclic AMP production and relay were clearly seen. Extracellular phosphodiesterase induction by cyclic AMP and phosphodiesterase inhibitor production were normal. These results indicate that the generation of chemotactic signals and the cellular responses to cyclic AMP are not severely affected by the mutation.


Subject(s)
Dictyostelium/genetics , Glycoproteins/analysis , Membrane Proteins/analysis , Mutation , Antibodies, Fungal/immunology , Antibodies, Monoclonal/immunology , Cell Aggregation , Chemotaxis , Dictyostelium/immunology , Microscopy, Electron, Scanning , Molecular Weight
5.
EMBO J ; 3(11): 2663-70, 1984 Nov.
Article in English | MEDLINE | ID: mdl-16453571

ABSTRACT

Wheat germ agglutinin (WGA), a lectin that primarily reacts with N-acetylglucosamine residues, specifically inhibits the EDTA-stable type of intercellular adhesion of aggregation competent Dictyostelium discoideum cells. The major WGA-binding protein of these cells is a developmentally-regulated glycolipoprotein of 80 kd apparent mol. wt., designated as contact site A. This glycoprotein is a target site of antibody fragments that block the EDTA-stable cell adhesion, and is characterized by sulfated carbohydrate residues. WGA does not significantly bind to glycoproteins of a mutant, HL220, which produces a 68-kd component in place of the 80-kd glycoprotein. Inhibition of N-glycosylation by tunicamycin causes wild-type cells to produce a WGA-binding but unsulfated 66-kd component and a non-binding 53-kd component. These results indicate that the 80-kd glycoprotein contains two classes of carbohydrate residues, a WGA-binding one that is defective in HL220, and another, sulfated, one that is absent from the 66-kd wild-type product; both are missing in the 53-kd protein. WGA and a monoclonal antibody that is blocked by N-acetylglucosamine were further used to probe for glycoproteins in the multicellular slug stage that share carbohydrate structures - and possibly functions - with the contact site A glycoprotein. Glycoproteins in the 95-kd range have previously been implicated in cell-to-cell adhesion during the slug stage. We distinguished a 95-kd glycoprotein that binds WGA from another one that binds antibody.

6.
Strahlentherapie ; 157(9): 600-6, 1981 Sep.
Article in German | MEDLINE | ID: mdl-7347438

ABSTRACT

After neutron and X-ray irradiation and combined X-ray irradiation and hyperthermia (3 hours, 42 degrees C), the survival rate of human melanoma cells was measured by means of the colony formation test and compared to the formation of micronuclei. Neutrons had a stronger effect on the formation of micronuclei than the combination of X-rays and hyperthermia. X-rays had the lowest effect. The dose effect curve showed a break at that dose level at which a reduction of cells was observed in the cultures. A good relation between survival rate and formation of micronuclei was found for the X-ray irradiation, but not for the neutron irradiation and the combined treatment. These observations are discussed. At least for X-rays, the micronucleus test has turned out to be a good screening method for the radiosensitivity of a biologic system.


Subject(s)
Melanoma/radiotherapy , Cell Line , Cell Nucleus/radiation effects , Colony-Forming Units Assay , Dose-Response Relationship, Radiation , Fever , Humans , Neutrons
SELECTION OF CITATIONS
SEARCH DETAIL
...